FIFTH SCHEDULE [Refer rules 20(3), 20(5), 20(8), 22(i)] QUALITY MANAGEMENT SYSTEM FOR MEDICAL DEVICES AND IN VITRO DIAGNOSTIC MEDICAL DEVICES 1. General Requirements: 1.1 This Schedule specifies requirements for a quality management system that shall be used by the manufacturer for the design and development, manufacture, packaging, labelling, testing, installation and servicing of medical device ...

Accredited Consultants Pvt. Ltd We are an ISO 10002:2004, ISO 9001:2008 Company and India’s most trusted management consulting firm with over 15 years of experience in the business. We collaborate with visionary leaders, institutions, ministries, research organizations & regulatory bodies from all sectors and spectrum to help you enter India’s vibrant market with most suited and in-depth strategy ...

6. However, accelerated approval should be used for a drug that represent significant advances over existing treatment or in case there is an unmet medical need for the indication for which the drug is intended, orphan drug for rare disease etc. in accordance with the provision prescribed under Second Schedule of ND& CT Rules, 2019. 7. ND & CT rules recognize the consideration of surrogate endpoin ...